Literature DB >> 18523062

Molecualr imaging of cancer: from molecules to humans. Introduction.

Sanjiv Sam Gambhir1.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18523062     DOI: 10.2967/jnumed.108.053751

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  8 in total

Review 1.  Non-FDG PET in oncology.

Authors:  R Núñez Miller; M A Pozo
Journal:  Clin Transl Oncol       Date:  2011-11       Impact factor: 3.405

2.  FDG PET in Prostate Cancer.

Authors:  Hossein Jadvar
Journal:  PET Clin       Date:  2009-04-01

Review 3.  PET/SPECT imaging agents for neurodegenerative diseases.

Authors:  Lin Zhu; Karl Ploessl; Hank F Kung
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

4.  On Launching a New Twenty-first Century Quarterly Journal, Nuclear Medicine and Molecular Imaging.

Authors:  Yong-Whee Bahk
Journal:  Nucl Med Mol Imaging       Date:  2010-04

Review 5.  18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization.

Authors:  Hossein Jadvar; Abass Alavi; Sanjiv S Gambhir
Journal:  J Nucl Med       Date:  2009-10-16       Impact factor: 10.057

Review 6.  Molecular imaging of prostate cancer with 18F-fluorodeoxyglucose PET.

Authors:  Hossein Jadvar
Journal:  Nat Rev Urol       Date:  2009-05-12       Impact factor: 14.432

Review 7.  Altered glutamine metabolism and therapeutic opportunities for lung cancer.

Authors:  Amr Mohamed; Xingming Deng; Fadlo R Khuri; Taofeek K Owonikoko
Journal:  Clin Lung Cancer       Date:  2013-11-13       Impact factor: 4.785

8.  In vivo bioimaging tracks conditionally replicative adenoviral replication and provides an early indication of viral antitumor efficacy.

Authors:  Julia Davydova; Tatyana Gavrikova; Eric J Brown; Xianghua Luo; David T Curiel; Selwyn M Vickers; Masato Yamamoto
Journal:  Cancer Sci       Date:  2009-10-20       Impact factor: 6.716

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.